Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy

Background: Hepatocellular carcinoma (HCC) is an aggressive cancer with poor prognosis. Although recent research has indicated that selective serotonin reuptake inhibitors (SSRIs), including escitalopram, have anticancer effects, little is known about the effects of escitalopram on HCC. Methods: Bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li-Jeng, Hsu, Tsai-Ching, Chan, Hsiang-Lin, Lin, Chiao-Fan, Huang, Jing-Yu, Stewart, Robert, Tzang, Bor-Show, Chen, Vincent Chin-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408912/
https://www.ncbi.nlm.nih.gov/pubmed/36012510
http://dx.doi.org/10.3390/ijms23169247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408912/
https://www.ncbi.nlm.nih.gov/pubmed/36012510
http://dx.doi.org/10.3390/ijms23169247

Ejemplares similares